Have a personal or library account? Click to login
ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients Cover

ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients

Archives of Industrial Hygiene and Toxicology
Volume 71 (2020): Issue 4 (December 2020)
By: Davorka Sutlović,  Željko Ključević and  Sendi Kuret  
Open Access
|Dec 2020

Authors

Davorka Sutlović

dsutlovic@ozs.unist.hr

University of Split, Department for Health Studies, Split, Croatia
University of Split School of Medicine, Department of Toxicology and Pharmacogenetics, Split, Croatia

Željko Ključević

Public Health Institute of the Split-Dalmatia County, Department of Mental Health, Prevention and Outpatient Addiction Treatment, Split, Croatia

Sendi Kuret

University of Split, Department for Health Studies, Split, Croatia
University Hospital Centre Split, Department of Pathology and Forensic Medicine, Split, Croatia
DOI: https://doi.org/10.2478/aiht-2020-71-3378 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Journal RSS Feed
Language: English, Croatian, Slovenian
Page range: 353 - 358
Submitted on: Dec 1, 2019
Accepted on: Nov 1, 2020
Published on: Dec 31, 2020
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
EDDP,
genotyping,
hepatitis C,
liver damage,
SNP
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2020 Davorka Sutlović, Željko Ključević, Sendi Kuret, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 71 (2020): Issue 4 (December 2020)Next article